Arrowhead Pharmaceuticals, Inc. (ARWR) vs Kymera Therapeutics, Inc. (KYMR)
- Arrowhead Pharmaceuticals, Inc. ARWR 55.90 −4.44%
- Kymera Therapeutics, Inc. KYMR 104.78 −3.11%
Arrowhead Pharmaceuticals, Inc. and Kymera Therapeutics, Inc. are both Biotechnology companies. Arrowhead Pharmaceuticals, Inc. and Kymera Therapeutics, Inc. are of similar size ($9.0B and $8.3B). Kymera Therapeutics, Inc. grew revenue faster over the last twelve months: 134.8% against 16.1%. Arrowhead Pharmaceuticals, Inc. has the higher net margin (−47.8% vs −285.3%) and the higher return on invested capital (0.00% vs −26.7%). Across the 17 metrics below, Arrowhead Pharmaceuticals, Inc. leads on 11 and Kymera Therapeutics, Inc. on 6.
Valuation
Profitability
| Metric | ARWR | KYMR | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (33.82%) | (333.50%) | 0.00% |
| Net margin | (47.79%) | (285.33%) | 0.00% |
| Free cash flow margin | (11.22%) | (226.62%) | 0.00% |
| Return on equity | (64.91%) | (24.15%) | (56.36%) |
| Return on assets | (18.32%) | (21.58%) | (48.04%) |
| Return on invested capital | 0.00% | (26.72%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack